ArticleJournal of shoulder and elbow arthroplasty2026
Stemless arthroplasty for avascular necrosis of the humerus: implant survival and outcomes.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Avascular necrosis (AVN) of the humeral head often affects younger patients and may lead to progressive pain and functional deficits. While stemmed hemiarthroplasty and total shoulder arthroplasty (TSA) are established treatments for advanced-stage AVN, stemless arthroplasty offers potential advantages including bone preservation and facilitation of future revision. However, the impact of bone necrosis on stemless humerus fixation is yet to be elucidated. Therefore, the purpose of this study was to evaluate the outcomes of stemless hemiarthroplasty and TSA in treating humeral head AVN and, further, to determine if stemless humeral fixation is appropriate in this population. Methods: This retrospective case series identified patients treated for humeral head AVN at a single academic medical center between 2013 and 2023. Patients undergoing stemless hemiarthroplasty or stemless TSA with a minimum of 2 years of clinical follow-up were included. Demographic data, operative characteristics, range of motion, Patient-Reported Outcomes Measurement Information System scores, revision surgery, and implant survival were recorded. Results: Twenty-three patients (27 shoulders) underwent stemless arthroplasty for AVN, including 18 hemiarthroplasties and 9 TSAs. The mean age was 39.7 ± 14.4 years, with a mean follow-up of 4.8 ± 1.9 years. The overall cohort demonstrated increases in mean forward flexion from 129.3° to 151.5°, external rotation from 40.5° to 52.8°, and abduction from 110.8° to 120.0°. Patient-Reported Outcomes Measurement Information System Pain Interference scores improved from 63.43 to 58.84 at final follow-up, Physical Function scores improved from 36.00 to 42.15, and Depression scores improved from 47.86 to 45.50. Two hemiarthroplasty patients required revision surgery, while no TSA patient underwent revision. One unrevised TSA demonstrated radiographic osteolysis with suspected loosening. Conclusion: Hemiarthroplasty and stemless TSA for humeral head AVN were associated with favorable mid-term outcomes and high implant survival. Stemless arthroplasty may represent a viable treatment option for select patients with humeral head AVN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.